Home Medicine Scotland Hits ‘Pause’ on Puberty Blockers, Hormone Drugs for Kids

Scotland Hits ‘Pause’ on Puberty Blockers, Hormone Drugs for Kids

by Universalwellnesssystems

Scotland has officially stopped prescribing puberty blockers and hormones to minors following the release of a damning report into the dangers of child sex reassignment procedures.

Sandyford Sexual Health Services, based in Glasgow, Scotland’s only gender clinic for minors; announced On Thursday, the government announced it would no longer refer children under 18 to pediatric endocrinologists for prescriptions for puberty blockers or hormones.

Earlier this month, the UK government announced: Cass reviewis a long-awaited nearly 400-page report compiled by respected pediatrician Dr. Hilary Cass on the gender reassignment procedure for children. Cass said he worked on this report for four years.

“The reality is that there is insufficient evidence about the long-term outcomes of interventions to manage gender-related distress,” the report declares. “This is an area where the evidence is significantly weaker.”

Sandyford Sexual Health Services announced:

Updates to this service are based on NHS research [National Health Service] We are working with the Scottish Government and NHS England on research to generate evidence of the safety and long-term effectiveness of the treatment. While this pause is in place, we will continue to provide everyone referred to our Youth Gender Service with the psychological support they need while we consider pathways in line with our findings.

The decision by Sandyford Sexual Health Services to “pause” the prescription of puberty blockers and hormones to children comes after new guidance From the National Health Service in Glasgow and Clyde.

“Based on clinical advice, NHS Greater Glasgow and Clyde and NHS Lothian have responded to NHS England’s position and have confirmed that, pending publication of the ‘Cass Review’, we will not be providing these services to new patients. “We have postponed the start of treatment to mid-March 2024,” the National Health Service said. Greater Glasgow and Clyde said in a written statement. “Following the publication of the Cass Review, and with support from Scotland’s Chief Medical Officer Sir Gregor Smith, the health board formally suspended treatment.”

Last month, NHS England officially announced stopped They prescribe puberty blockers and hormones to their children, explaining: “Puberty blockers are not available to children and youth with gender nonconformity or gender dysphoria because there is insufficient evidence of safety and clinical efficacy.”

NHS England warned that hormones “cause irreversible changes” and “may cause temporary or permanent infertility”. The agency further stated that “there is uncertainty regarding the risks of long-term heterosexual hormone therapy.”

Instead of such a prescription, NHS England says that children diagnosed with gender dysphoria should receive family therapy, individual child psychotherapy, parental support and counseling, and “regular visits to monitor the development of gender identity.” He explained that a variety of psychological treatments are available, including “review.”

NHS England explained its new guidance as follows: “Most of the treatments currently available are psychological rather than medical. This is because gender-specific behaviors and emotions often disappear as children reach adolescence.”

Basu’s landmark report found that child sex reassignment procedures were largely based on biased and even low-quality research.

Additionally, the report found that despite the common claims of many gender transition advocates, there is “no evidence” that gender transition procedures prevent or reduce the risk of suicide. Prescribing puberty blockers and hormones to minors can be dangerous. The majority of children diagnosed with gender dysphoria have a number of psychological comorbidities that are often ignored. And the practice of gender transition procedures has largely been guided by “harmful” arguments and discourses.

The Cass Review has already led to what British authorities call “fundamental changes” to the sex change industry, as evidenced by Scotland’s shift in policy on puberty blockers and hormones.

In the process of compiling her report, Cass researched the gender identity development service at London’s Tavistock Infirmary. Her findings led pediatricians to recommend that the government close the clinic immediately, nearly two years before the final report was submitted.

In particular, Ms Kath was concerned about the tendency of Tavistock staff to put children as young as 10 years old on puberty blockers and hormones after just three counseling sessions and with little or no psychological monitoring. I was upset. Cass noted with alarm that around 96% of children who consulted Tavistock were prescribed puberty-suppressing drugs.

“We believe that the toxicity surrounding public debate is impacting on the lives of young people seeking care in our services and is not helping the teams working hard to care for and support them. “I agree with Dr. Hilary Cass,” said Dr. Emelia Clayton of Public Health. The director of the Glasgow and Clyde Metropolitan Area National Health Service said in a written statement.

“The findings that informed the Cath review were significant and we considered the impact on clinical pathways,” Mr Clayton said. “The next step from here is to work with the Scottish Government and academic partners to generate evidence that will enable us to provide safe care to our patients.”

Tracey Gillies, NHS Lothian’s executive medical director, said: “The Cass Review is an important piece of work into how the NHS can better support children and young people with gender dysphoria.” Patient safety is always our top priority and we will carry out further research. It is right to pause this treatment while you can. ”

Meanwhile, U.S. health officials continue to promote sex change procedures for children that include puberty blockers and hormones. In last year’s report, named The United States has been labeled an “outlier” in protecting children from harmful sex change procedures, after France, Sweden, Finland, Norway and the United Kingdom issued warnings against prescribing puberty blockers and hormones to children. became.

Request filed under the Freedom of Information Act earlier this year as a result In a confessional by U.S. Department of Health and Human Services Assistant Secretary Rachel Levine, her assertion that child gender transition procedures are “lifesaving” and “necessary” cites a single study conducted. He admitted that it was based entirely on a two-page document that he wrote. By an LGBT activist group.

It was first published washington stand

You may also like

Leave a Comment

The US Global Health Company is a United States based holistic wellness & lifestyle company, specializing in Financial, Emotional, & Physical Health.  

Subscribe my Newsletter for new blog posts, tips & new photos. Let's stay updated!

Copyright ©️ All rights reserved. | US Global Health